Rare Diseases Report 2021

Rare GU cancers: Overcoming obstacles through collaboration, novel trial design


 

Pages

Recommended Reading

Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomes
MDedge Hematology and Oncology
In and out surgeries become the norm during pandemic
MDedge Hematology and Oncology
Overall survival for metastatic urothelial carcinoma approaching 2 years
MDedge Hematology and Oncology
Dogs show potential as medical detectives in breast cancer
MDedge Hematology and Oncology
Severe COVID two times higher for cancer patients
MDedge Hematology and Oncology
Prostate cancer risk higher with Lynch syndrome variants
MDedge Hematology and Oncology
Urine test for prostate cancer signals amount of aggressive tumor
MDedge Hematology and Oncology
Shock, disbelief as NCCN changes prostate cancer guidance
MDedge Hematology and Oncology
After doc uproar, NCCN reverses prostate cancer guidance
MDedge Hematology and Oncology
LGBTQ health care: There is reason to be hopeful
MDedge Hematology and Oncology